Evolving Targets for Risk Reduction in Diabetes

Gregory M. Caputo, Joel B. Braunstein, Roger S. Blumenthal

Research output: Contribution to journalReview article

Abstract

Recent evidence shows that target low-density lipoprotein cholesterol should be less than 100 mg/dl in patients with diabetes, and that even those with initially low levels benefit from pharmacologic therapy. Recent studies document that blood pressures lower than the previous target of 140/90 mmHg are beneficial, in addition to providing observational evidence against a lower threshold of benefit. Evidence that addresses the effect of blood glucose on macrovascular disease risk in patients with diabetes is reviewed. Finally, recommendations are made regarding systematic changes in healthcare delivery that will facilitate risk reduction strategies in diabetes.

Original languageEnglish (US)
Pages (from-to)125-128
Number of pages4
JournalClinical Cardiology
Volume27
Issue number3
DOIs
StatePublished - Mar 2004

    Fingerprint

Keywords

  • Blood pressure
  • Cholesterol
  • Diabetes mellitus
  • Glucose
  • Hyperlipidemia
  • Hypertension
  • Lipids

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this